1991
DOI: 10.1016/0378-5122(91)90300-f
|View full text |Cite
|
Sign up to set email alerts
|

Vaginosonography for early detection of endometrial carcinoma?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
46
0
6

Year Published

1994
1994
2013
2013

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(55 citation statements)
references
References 0 publications
3
46
0
6
Order By: Relevance
“…Thus, the use of endometrial thickness as the only indicator for invasive assessment implies a large number of false positives, even at TVUS diagnosis, and of unnecessary assessments (Osmers et al, 1990;Ciatto et al, 1995). In the present study only a cutoff of X3 mm would be totally safe, granting for no missed cancer, but it would allow a limited (25.8%) reduction of unnecessary invasive assessments.…”
Section: Discussionmentioning
confidence: 59%
See 1 more Smart Citation
“…Thus, the use of endometrial thickness as the only indicator for invasive assessment implies a large number of false positives, even at TVUS diagnosis, and of unnecessary assessments (Osmers et al, 1990;Ciatto et al, 1995). In the present study only a cutoff of X3 mm would be totally safe, granting for no missed cancer, but it would allow a limited (25.8%) reduction of unnecessary invasive assessments.…”
Section: Discussionmentioning
confidence: 59%
“…For this reason, special surveillance for EC has been suggested in breast cancer patients under adjuvant tamoxifen treatment (Jordan and Morrow, 1994;Neven et al, 1994) and periodic examination by transvaginal ultrasonography (TVUS) is commonly performed (Oladipo, 1993;Kedar et al, 1994). Increased endometrial thickness measured at TVUS has been reported as an indicator of endometrial proliferation and EC risk (Karlsson et al, 1995;Weber et al, 1997) and has been suggested as a criterion to prompt invasive diagnostic assessment (hysteroscopy, dilatation and curettage) in postmenopausal asymptomatic or symptomatic (AUB ¼ abnormal uterine bleeding) women (Goldstein et al, 1990;Osmers et al 1990;Cecchini et al, 1996;Langer et al, 1997;SmithBindman et al, 1998).…”
mentioning
confidence: 99%
“…In the postmenopausal period, different cut-off values for endometrial thickness have been proposed to determine whether additional investigation is required, particularly in asymptomatic women who carry a lower risk of malignancy compared with women with genital bleeding [18][19][20] . For focal endometrial lesions where the adjacent endometrium has an atrophic pattern, these cut-off values are poorly defined.…”
Section: Discussionmentioning
confidence: 99%
“…All patients underwent a gynecological evaluation, vaginal ultrasonography combined with color flow images of the uterine arteries, and endometrial biopsy, performed during a hysteroscopic examination. All patients had been treated with 20 to 30 mg of tamoxifen daily (Abic Ltd., Chemical and Pharmaceutical Industries, Netanya, Israel) for a period of 12 to 42 months (mean, 21.18 months). Informed consent was obtained from each patient after the nature of the study was fully explained.…”
Section: Methodsmentioning
confidence: 99%